Spencer-Sandino, MariaRiquelme-Neira, RobertoShropshire, William C.Dinh, An Q.González-Rocha, GerardoGonzález-Muñoz, PaulinaVera-Leiva, AlejandraAraos, RafaelHanson, BlakeArias, Cesar AMunita, José2022-01-112022-01-112021Maria Spencer-Sandino, Roberto Riquelme-Neira, William C Shropshire, An Q Dinh, Gerardo González-Rocha, Paulina González-Muñoz, Alejandra Vera-Leiva, Rafael Araos, Blake Hanson, Cesar A Arias, José M Munita, Descontaminación digestiva selectiva con colistina oral más gentamicina para la bacteriemia persistente causada por Klebsiella pneumoniae resistente a los carbapenemas no productora de carbapenemasas en un paciente neutropénico, JAC-Resistencia a los antimicrobianos , volumen 3, número 2, junio de 2021, dlab079, https://doi.org/10.1093 /jacamr/dlab079https://doi.org/10.1093 /jacamr/dlab079http://hdl.handle.net/11447/5418Carbapenem-resistant Klebsiella pneumoniae (CRKp) have become an increasing public health problem worldwide. While most CRKp around the world harbour a carbapenemase enzyme, the clinical relevance of non-carbapenemase-producing CRKp (non-CP-CRKp) is increasingly recognized. Selective digestive decontamination (SDD) has been proven successful as a decolonization strategy for patients colonized with Gram-negatives in the ICU. However, it is not regularly used to treat invasive infections.enphenotypegentamicin sulfatebacteremianeutropeniagentamicinsgene amplificationgastrointestinal systemintensive care unitintestinesklebsiella pneumoniaemicrobial colonizationbloodstream infectionsdigestive tract decontaminationcarbapenem resistanceArticle